​

IN8bio (INAB) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

INAB Stock Forecast

IN8bio (INAB) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $4.00, with a high of $4.00 and a low of $4.00. This represents a 109.42% increase from the last price of $1.91.

High: $4 Avg: $4 Low: $4 Last Closed Price: $1.91

INAB Stock Rating

IN8bio stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

INAB Price Target Upside V Benchmarks

TypeNameUpside
StockIN8bio109.42%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$4.00
Last Closing Price$1.91$1.91$1.91
Upside/Downside--109.42%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2613---4
Feb, 2613---4
Jan, 2613---4
Dec, 2513---4
Nov, 2522---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 13, 2025Mizuho Securities$4.00$2.1189.57%109.42%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 03, 2024LaidlawBuyBuyhold
Aug 30, 2022H.C. WainwrightBuyinitialise

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.00$-0.57$-4.44---
Avg Forecast$-0.90$-0.56$-0.28$-0.31$-0.25$-0.05
High Forecast$-0.90$-0.53$-0.23$-0.17$-0.15$-0.05
Low Forecast$-0.90$-0.59$-0.31$-0.69$-0.43$-0.05
Surprise %11.11%1.79%1485.71%---

Revenue Forecast

$0 $10M $20M $30M $40M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$9.20M$47.67M$2.67M$22.74M
High Forecast--$9.20M$47.67M$2.67M$22.74M
Low Forecast--$9.20M$47.67M$2.67M$22.74M
Surprise %------

Net Income Forecast

$-35M $-28M $-21M $-14M $-7M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-30.01M$-30.44M$-19.44M---
Avg Forecast$-26.98M$-16.82M$-8.03M$-12.92M$-8.64M$-1.42M
High Forecast$-26.98M$-15.92M$-6.78M$-5.17M$-4.39M$-1.42M
Low Forecast$-26.98M$-17.73M$-9.28M$-20.67M$-12.90M$-1.42M
Surprise %11.23%80.92%141.96%---

INAB Forecast FAQ

Is IN8bio stock a buy?

IN8bio stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that IN8bio is a favorable investment for most analysts.

What is IN8bio's price target?

IN8bio's price target, set by 4 Wall Street analysts, averages $4 over the next 12 months. The price target range spans from $4 at the low end to $4 at the high end, suggesting a potential 109.42% change from the previous closing price of $1.91.

How does IN8bio stock forecast compare to its benchmarks?

IN8bio's stock forecast shows a 109.42% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for IN8bio over the past three months?

  • March 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is IN8bio’s EPS forecast?

IN8bio's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.31, marking a -93.02% decrease from the reported $-4.44 in 2025. Estimates for the following years are $-0.25 in 2027, and $-0.05 in 2028.

What is IN8bio’s revenue forecast?

IN8bio's average annual revenue forecast for its fiscal year ending in December 2026 is $47.67M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $2.67M, and $22.74M for 2028.

What is IN8bio’s net income forecast?

IN8bio's net income forecast for the fiscal year ending in December 2026 stands at $-12.921M, representing a -33.53% decrease from the reported $-19.44M in 2025. Projections indicate $-8.643M in 2027, and $-1.419M in 2028.